About Canax

CO2 extraction specialist, to accelerate and support the world's transition from synthetic therapy into Cannabis derived pharmaceutical solution, and the integration of Cannabis, Hemp, and other plant derived extracts into the day-to-day life.

Company Highlights
Year Founded

2019

icon-altEmployees

4

Location (HQ)

ITA

Since Last Funding

2 years 5 months

Monthly Website Visitors

4.1K

icon-altTotal Investment Amt

$2.9M

Last Funding Round

Debt Financing

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Biotechnology Research

Medical

Pharmaceutical

Cannabis